U.S., March 25 -- ClinicalTrials.gov registry received information related to the study (NCT06891170) titled 'B Cell Responses in COVID-19' on March 21.
Brief Summary: In this study, we will develop techniques to optimize the in vitro production of human monoclonal antibodies.
Study Start Date: July 07, 2021
Study Type: OBSERVATIONAL
Condition:
COVID 19
Recruitment Status: ACTIVE_NOT_RECRUITING
Sponsor: Fondazione IRCCS Policlinico San Matteo di Pavia
Information provided by (Responsible Party): Barbara Oliviero, Fondazione IRCCS Policlinico San Matteo di Pavia
Published by HT Digital Content Services with permission from Health Daily Digest....